Company Analysis
Sign in

CorMedix Inc. (CRMD)

Nasdaq: CRMD · Pharmaceutical Preparations · Parsippany, NJ · filing with the SEC since 2007
Full chart Alerts Compare
Grade6.3
◀ Past 4.7● Present 6.8▶ Future 7.4
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

90 patents granted to the 13 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to CorMedix Inc.’s names, not what it holds today.

Patents granted
90
89 utility, 1 reissue, 1976 to Dec 31, 2025
Granted in 2025
2
Against 8 in 2024 and 3 in 2023
Applications published
166
6 of them in 2025
Names they are printed under
13
a subsidiary, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals14
Chemical engineering1
Organic fine chemistry1
Basic materials chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name13 counted
REMPEX PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent
27 granted
11 published
CEMPRA PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent
19 granted
13 published
Melinta Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
32 published
MELINTA THERAPEUTICS, INC. a subsidiary
US, as the owner printed on each patent
23 granted
5 published
CorMedix Inc. its own name
named as the applicant on its applications, in US
0 granted
27 published
Rempex Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
27 published
CEMPRA PHARMACEUTICALS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
23 published
Melinta Subsidiary Corp. a subsidiary
named as the applicant on its applications, in US
0 granted
15 published
MELINTA SUBSIDIARY CORP. a subsidiary
US, as the owner printed on each patent
14 granted
0 published
CorMedix Inc. its own name
US, as the owner printed on each patent
7 granted
2 published
Targanta Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent. 6 more under the same name are not counted (printed in CA)
0 granted
8 published
CEM-102 PHARMACEUTICALS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
CEM-102 PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 25, 202512,478,606Methods of treating bacterial infectionsPharmaceuticalsMELINTA SUBSIDIARY CORP.
May 20, 202512,302,902Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilmsBasic materials chemistryCorMedix Inc.
Dec 24, 202412,171,772Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesPharmaceuticalsMELINTA SUBSIDIARY CORP.
Dec 10, 202412,161,656Tetracycline compositionsPharmaceuticalsMELINTA SUBSIDIARY CORP.
Nov 12, 202412,138,257Antimicrobial compositionsPharmaceuticalsMELINTA SUBSIDIARY CORP.
Aug 6, 202412,053,478Taurultam, taurinamide and methylene glycol treatment for MYC-expressing tumors in mammalian bodiesPharmaceuticalsCorMedix Inc.
Jul 16, 202412,036,219Methods of treating infections in overweight and obese patients using antibioticsPharmaceuticalsMELINTA SUBSIDIARY CORP.
Jun 25, 202412,016,865Methods and pharmaceutical compositions for treating candida auris in bloodPharmaceuticalsCorMedix Inc.
Jun 4, 202411,999,757Synthesis of boronate ester derivatives and uses thereofOrganic fine chemistryMELINTA SUBSIDIARY CORP.
Apr 2, 202411,944,634Tetracycline compositionsPharmaceuticalsMELINTA SUBSIDIARY CORP.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0374925ANTIMICROBIAL COMPOSITIONS, INCLUDING ANTIMICROBIAL HYDROGELS, EFFECTIVE AGAINST MATURE BIOFILMSBasic materials chemistryCorMedix Inc.
Aug 7, 20252025/0249153Improved Synthesis of Taurolidine, Purity Profiles and PolymorphsPharmaceuticalsCorMedix Inc.
May 8, 20252025/0144111TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIESPharmaceuticalsCorMedix Inc.
Mar 27, 20252025/0099480METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOODPharmaceuticalsCorMedix Inc.
Feb 27, 20252025/0064838THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVESPharmaceuticalsMelinta Subsidiary Corp.
Feb 13, 20252025/0049820TETRACYCLINE COMPOSITIONSPharmaceuticalsMelinta Subsidiary Corp.
Sep 19, 20242024/0307368ANTIMICROBIAL COMPOSITIONSPharmaceuticalsMelinta Subsidiary Corp.
Aug 22, 20242024/0279248SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOFOrganic fine chemistryMelinta Subsidiary Corp.
Jun 13, 20242024/0189326TETRACYCLINE COMPOSITIONSPharmaceuticalsMelinta Subsidiary Corp. · patent 12,161,656 granted from it
May 23, 20242024/0165100METHODS OF TREATING INFECTIONS IN OVERWEIGHT AND OBESE PATIENTS USING ANTIBIOTICSPharmaceuticalsMelinta Subsidiary Corp.
What it applied for, 2024 to 2025: Pharmaceuticals 8 · Organic fine chemistry 1 · Basic materials chemistry 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CRMD · research, not advice